Answers are grounded in this paper and cite their sources.
Introduction: Population-level obstructive sleep apnea (OSA) underdiagnosis is attributable in part to sleep testing challenges. Consumer interest has driven the rise of patient wearables as an easy alternative assessment of sleep. Newer home sleep apnea tests have crossover utility between patient wearable and medical grade information. This study assessed patient benefits of crossover sleep apnea testing (XSAT) in a dental clinic. Methods: A convenience sample of consecutive patients choosing XSAT (N=52) were assessed for sleep testing satisfaction in a retrospective observational study through a phone follow-up survey. Results: Two patients dropped out, and 41 completed the survey (82% response). Satisfaction with XSAT was high/very high in 93% of all survey-responders, and 100% of nave (no past professional sleep test) survey-responders, with 1.2%experiencing technical problems. Failed test-nights occurred in 5.7% (8/141) test-nights with no failed studies. Average number of sleep-test nights were 2.8 (3.0 for nave, 2.5 non-nave). Twelve of 14 nave survey-responders (six males, mean body mass index 26.9 kg/m 2 , mean age 48.4 years) had OSA (6 mild OSA). The night-to-night variability using 3% apnea-hypopnea criteria was 6.3 events/hr for nave, 6.0 for all survey-responders, and 6.4 for all patients. XSAT benefit of "no need to return equipment" was important to 85% of non-nave versus 64% of nave survey-responders.
No takes yet. Share an insight, caveat, or question.
Simmons et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: